Large scale clinical trials demonstrate significant reductions in cardiovascular event rates with statin therapy. The observed benefit of statin therapy, however, may be larger in these trials than that expected on the basis of lipid lowering alone. Emerging evidence from both clinical trials and basic science studies suggest that statins have anti-inflammatory properties, which may additionally lead to clinical efficacy. Measurement of markers of inflammation such as high sensitivity C-reactive protein in addition to lipid parameters may help identify those patients who will benefit most from statin therapy
The explosion of medical knowledge and the importance and real reductions in adverse cardiovascular ...
Current evidence suggests that statin use decreases the incidence of cardiovascular diseases (CVD) t...
Dysregulated lipid metabolism induces an inflammatory and immune response leading to atherosclerosis...
During the past 2 decades, atherosclerosis and its clinical sequelae have increasingly been recogniz...
Abstract: Ample evidence exists in support of the potent anti-inflammatory properties of statins. In...
Anti-inflammatory activities of statins in atherosclerosis have been well documented by both basic r...
Inflammation is an integral part of atherosclerosis,both in its early phases and in acute coronarysy...
Inflammatory changes are responsible for maintenance of the atherosclerotic process and may underlie...
Anti-inflammatory and immunomodulatory effects of statins. 3-Hydroxy-3-methyl-gutaryl coenzyme A (HM...
Background: Low density lipoprotein cholesterol (LDL-C) and low grade arterial inflammation are key ...
This article contains information from a talk given by the author at the RMS on 14/01/03, entitled: ...
Dyslipidaemia and inflammation are closely interconnected in their contribution to atherosclerosis. ...
INTRODUCTION Statins, also known as 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductase inh...
Introduction: Statins, also known as 3-Hydroxy-3-Methylglutaryl Co-A (HMG-CoA) reductase inhibitors,...
Atherosclerosis is a chronic inflammatory disorder of the vasculature where cholesterol accumulates ...
The explosion of medical knowledge and the importance and real reductions in adverse cardiovascular ...
Current evidence suggests that statin use decreases the incidence of cardiovascular diseases (CVD) t...
Dysregulated lipid metabolism induces an inflammatory and immune response leading to atherosclerosis...
During the past 2 decades, atherosclerosis and its clinical sequelae have increasingly been recogniz...
Abstract: Ample evidence exists in support of the potent anti-inflammatory properties of statins. In...
Anti-inflammatory activities of statins in atherosclerosis have been well documented by both basic r...
Inflammation is an integral part of atherosclerosis,both in its early phases and in acute coronarysy...
Inflammatory changes are responsible for maintenance of the atherosclerotic process and may underlie...
Anti-inflammatory and immunomodulatory effects of statins. 3-Hydroxy-3-methyl-gutaryl coenzyme A (HM...
Background: Low density lipoprotein cholesterol (LDL-C) and low grade arterial inflammation are key ...
This article contains information from a talk given by the author at the RMS on 14/01/03, entitled: ...
Dyslipidaemia and inflammation are closely interconnected in their contribution to atherosclerosis. ...
INTRODUCTION Statins, also known as 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductase inh...
Introduction: Statins, also known as 3-Hydroxy-3-Methylglutaryl Co-A (HMG-CoA) reductase inhibitors,...
Atherosclerosis is a chronic inflammatory disorder of the vasculature where cholesterol accumulates ...
The explosion of medical knowledge and the importance and real reductions in adverse cardiovascular ...
Current evidence suggests that statin use decreases the incidence of cardiovascular diseases (CVD) t...
Dysregulated lipid metabolism induces an inflammatory and immune response leading to atherosclerosis...